HLA-C and neoplasm: As a consequence of this irradiation, dying tumour cells can release DAMPs that activate dendritic cells (DC) [19, 21] allowing them to travel to adjacent lymph nodes, present their tumour-associated antigenic material in the context of major histocompatibility complex (MHC) class I and class II molecules and induce both antigen-specific T- and B cell responses [18, 22].